Marc Zerbib

7.3k total citations
262 papers, 4.7k citations indexed

About

Marc Zerbib is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Marc Zerbib has authored 262 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Pulmonary and Respiratory Medicine, 107 papers in Surgery and 56 papers in Urology. Recurrent topics in Marc Zerbib's work include Bladder and Urothelial Cancer Treatments (83 papers), Prostate Cancer Diagnosis and Treatment (61 papers) and Prostate Cancer Treatment and Research (58 papers). Marc Zerbib is often cited by papers focused on Bladder and Urothelial Cancer Treatments (83 papers), Prostate Cancer Diagnosis and Treatment (61 papers) and Prostate Cancer Treatment and Research (58 papers). Marc Zerbib collaborates with scholars based in France, United States and Italy. Marc Zerbib's co-authors include B Debré, T Flam, Michaël Peyromaure, Nicolas Barry Delongchamps, Delphine Amsellem‐Ouazana, Annick Vieillefond, S Conquy, F. Cornud, Frédéric Beuvon and G. Pignot and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Marc Zerbib

241 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Zerbib France 34 2.3k 2.0k 880 862 776 262 4.7k
Hanjong Ahn South Korea 35 3.2k 1.4× 1.8k 0.9× 746 0.8× 1.3k 1.5× 574 0.7× 306 4.8k
Jonathan I. Izawa Canada 39 1.5k 0.7× 2.3k 1.2× 921 1.0× 625 0.7× 735 0.9× 159 4.2k
Ofer Yossepowitch Israel 35 3.4k 1.5× 1.8k 0.9× 740 0.8× 787 0.9× 608 0.8× 164 5.0k
Giovanni Lughezzani Italy 45 3.4k 1.5× 2.7k 1.4× 1.2k 1.4× 1.0k 1.2× 737 0.9× 276 5.8k
Stephanie Daignault United States 36 2.5k 1.1× 1.7k 0.8× 582 0.7× 2.0k 2.3× 1.2k 1.6× 123 5.1k
Hendrik Isbarn Germany 44 2.6k 1.1× 2.7k 1.4× 910 1.0× 946 1.1× 680 0.9× 159 5.2k
Vincent P. Laudone United States 33 2.0k 0.9× 1.9k 1.0× 835 0.9× 727 0.8× 747 1.0× 119 4.2k
Dipen J. Parekh United States 35 1.8k 0.8× 1.7k 0.9× 1.0k 1.1× 662 0.8× 462 0.6× 192 3.9k
Karl Pummer Austria 37 2.0k 0.9× 1.2k 0.6× 408 0.5× 1.0k 1.2× 1.0k 1.3× 156 4.1k
M’Liss A. Hudson United States 28 2.5k 1.1× 2.0k 1.0× 628 0.7× 784 0.9× 658 0.8× 58 4.5k

Countries citing papers authored by Marc Zerbib

Since Specialization
Citations

This map shows the geographic impact of Marc Zerbib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Zerbib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Zerbib more than expected).

Fields of papers citing papers by Marc Zerbib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Zerbib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Zerbib. The network helps show where Marc Zerbib may publish in the future.

Co-authorship network of co-authors of Marc Zerbib

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Zerbib. A scholar is included among the top collaborators of Marc Zerbib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Zerbib. Marc Zerbib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zerbib, Marc, Van Thuy Hoang, Jean‐Charles Beugnot, et al.. (2023). Observation of Brillouin scattering in a high-index doped silica chip waveguide. Results in Physics. 52. 106830–106830. 5 indexed citations
2.
Garinet, Simon, G. Pignot, Sophie Vacher, et al.. (2018). High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer. Molecular Cancer Research. 17(2). 469–475. 18 indexed citations
3.
Dabi, Yohann, et al.. (2016). Impact pronostique du genre féminin sur le devenir oncologique des patients traités par cystectomie totale. Progrès en Urologie. 26(2). 83–88. 2 indexed citations
4.
Pignot, G., Alexandre Rouquette, Annick Vieillefond, et al.. (2014). Tumeurs du haut appareil urinaire et syndrome de Lynch : doit-on proposer un dépistage systématique ?. Bulletin du Cancer. 101(2). 144–150. 7 indexed citations
5.
Xylinas, Évanguelos, Luis Kluth, Malte Rieken, et al.. (2013). Impact of smoking status and cumulative exposure on intravesical recurrence of upper tract urothelial carcinoma after radical nephroureterectomy. British Journal of Urology. 114(1). 56–61. 38 indexed citations
6.
Xylinas, Évanguelos, Michael Rink, Brian D. Robinson, et al.. (2013). Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. European Journal of Cancer. 49(8). 1889–1897. 130 indexed citations
7.
Pignot, G., Annick Vieillefond, Sophie Vacher, et al.. (2012). Hedgehog pathway activation in human transitional cell carcinoma of the bladder. British Journal of Cancer. 106(6). 1177–1186. 45 indexed citations
8.
Delongchamps, Nicolas Barry, et al.. (2011). Cancer de la prostate de stade pT3N0 traité par prostatectomie radicale en monothérapie : résultats carcinologiques et facteurs prédictifs de récidive. Progrès en Urologie. 22(2). 100–105. 1 indexed citations
9.
Delongchamps, Nicolas Barry, et al.. (2009). Mélanome primitif de l’urètre découvert au stade métastatique : à propos d’un cas. Progrès en Urologie. 20(1). 80–82. 3 indexed citations
10.
Amsellem‐Ouazana, Delphine, F. Cornud, S Conquy, et al.. (2006). Management of a malignant urinary fistula by ureteral embolization with coils. Urology. 68(2). 427.e1–427.e3. 9 indexed citations
11.
Peyromaure, Michaël & Marc Zerbib. (2003). T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival. British Journal of Urology. 93(1). 60–63. 35 indexed citations
12.
Zerbib, Marc & Olivier Bouchot. (2002). Qualité de vie et dérivation urinaire.. Progrès en Urologie. 12(5). 3 indexed citations
13.
Zerbib, Marc & Olivier Bouchot. (2002). Facteurs pronostiques de survie après cystectomie totale.. Progrès en Urologie. 12(5). 2 indexed citations
14.
Lecuit, Marc, Denis Chatelain, J. P. Courpied, et al.. (1999). [Tissue reactions to wear debris of joint prostheses. Diagnostic problems. Apropos of 2 cases].. PubMed. 85(6). 636–9. 1 indexed citations
15.
Thiounn, Nicolas, et al.. (1998). Endoscopic ureteroneocystostomy: palliative urinary diversion in advanced prostatic cancer.. PubMed. 4(1). 46–50. 3 indexed citations
16.
Zerbib, Marc & S Conquy. (1995). [Surgery of urinary incontinence in men].. PubMed. 45(3). 305–7. 2 indexed citations
17.
Flam, T, et al.. (1991). Laser Treatment of Obstruction from Incrusted Ureteral Catheter. The Journal of Urology. 145(2). 337–338.
18.
Zerbib, Marc, et al.. (1989). Sarcomes des tissus mous mésenchymateux rétro-péritonéaux et du cordon. A propos de neuf observations.. Annales d Urologie. 23(3). 2 indexed citations
19.
Zerbib, Marc, et al.. (1987). Carcinome épidermoïde de vessie: à propos de quarante-six observations. Annales d Urologie. 21(3). 3019–3022. 2 indexed citations
20.
Poisson, D.M., et al.. (1983). Maladie des synostoses multiples. Etude de la variation des symptômes dans une même famille.. 40(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026